CELLAVISION AB The information was submitted to the public on January 24, 2017 at 8:20 CET
CellaVision will publish the year-end bulletin for 2016 on February 7, 2017 at 08:20 CET. The report will be available at www.cellavision.com
In connection with the release of the year-end bulletin analysts, investors and media are hereby invited to a telephone conference and audio webcast at 10:00 CET where Zlatko Rihter, CEO, will present and comment the report.
The presentation will be in English via a conference call or audio webcast:
https://wonderland.videosync.fi/cellavision-q4-report-2016
Phone number for the conference:
UK: +442030089807
SE: +46856642693
US: +18558315946
No pre-registration is required. Please dial in 5-10 minutes prior to the scheduled start time in order to facilitate a timely start.
About CellaVision
CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in image analysis, artificial intelligence and automated microscopy. Sales are via global partners with support from the mother company in Lund and by the market support organizations in the US, Canada, China, Japan, Dubai, Korea, Australia and France. In 2015 sales were SEK 239 million and sales continue to increase, with a growth target of at least 15 % per year over an economic cycle. CellaVision's registered office is in Lund, Sweden. The share is listed on the Nasdaq Stockholm, Small Cap list. Read more at www.cellavision.com
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: CellaVision AB via Globenewswire
